Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13 tissue inhibitor of metalloproteinase 1 expression in murine silicosis

被引:41
|
作者
Ortiz, LA
Lasky, J
Gozal, E
Ruiz, V
Lungarella, G
Cavarra, E
Brody, AR
Friedman, M
Pardo, A
Selman, M
机构
[1] Tulane Univ, Med Ctr, Sect Pulm Dis Crit Care & Environm Med, Dept Pathol, New Orleans, LA 70112 USA
[2] Tulane Univ, Med Ctr, Lung Biol Program, New Orleans, LA 70112 USA
[3] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico
[5] Univ Siena, Ist Patol Gen, I-53100 Siena, Italy
关键词
D O I
10.1164/ajrccm.163.1.2002123
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Murine exposure to silica is associated with enhanced tumor necrosis factor alpha (TNF-alpha) expression and matrix deposition. The regulation of TNF is mediated through TNF receptor (TNFR) activation of transcription factors. In the present work we have studied the importance of the individual TNFR in silica-induced lung inflammation and matrix deposition in mice. We studied RNA expression of TNF, alpha1(I) collagen, interstitial collagenase (MMP-13), and its inhibitor (TIMP-1) in the lungs of silica-treated mice. Furthermore, we correlated MMP-13/TIMP-1 RNA abundance with activation of the transcription factors AP-1 and NF-kappaB in the lungs of C57BL/6 mice, and of mice deficient in one of the two types of TNFR (p55(-/-) or p75(-/-)), exposed to silica (0.2 g/kg) or saline by intratracheal instillation. Animals were killed 28 d after exposure and lung hydroxyproline (HP), TNF, alpha1(I) collagen, MMP-13, and TIMP-1 RNA abundance was measured. AP-1 and NF-kappaB activation was studied by gel-shift assays. Compared with C57BL/6 mice, p55(-/-) and p75(-/-) mice significantly (*p < 0.05) decreased lung HP accumulation in response to silica. All murine strains enhanced TNF and <alpha>1(I) collagen mRNA in response to silica. Enhanced (p < 0.05) MMP-13 RNA expression was also observed in all murine strains in response to silica. Enhanced (p < 0.05) TIMP-1 RNA expression was observed in C57BL/6 mice, but not in p55(-/-) or p75(-/-) mice, in response to silica. NF-KB activation was observed in all murine strains, whereas AP-1 activation was observed only in C57BL/6 mice after silica treatment. These data suggest that TNFR deletion modifies MMP-13/TIMP-1 expression in favor of matrix degradation.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 50 条
  • [31] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [32] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [33] Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1α and tumor necrosis factor-α through a prostaglandin-dependent pathway
    Lin, SK
    Wang, CC
    Huang, S
    Lee, JJ
    Chiang, CP
    Lan, WH
    Hong, CY
    JOURNAL OF ENDODONTICS, 2001, 27 (03) : 185 - 189
  • [34] Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition
    Lindsey, Merry L.
    Yabluchanskiy, Andriy
    Ma, Yonggang
    CARDIOLOGY, 2015, 132 (03) : 147 - 150
  • [35] Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin
    Prifti, S
    Lelle, I
    Zhong, G
    Strowitzki, T
    Rabe, T
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 18 (01) : 23 - 27
  • [36] Matrix metalloproteinase, hepatocyte growth factor, and tissue inhibitor of matrix metalloproteinase during human liver regeneration
    Fuke, H
    Saitou, Y
    Nakano, T
    Uemoto, S
    Shiraki, K
    LIVER INTERNATIONAL, 2006, 26 (03) : 380 - 381
  • [37] EFFECT OF PHORBOL ESTER AND CYTOKINES ON MATRIX METALLOPROTEINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE EXPRESSION IN TUMOR AND NORMAL-CELL LINES
    MACKAY, AR
    BALLIN, M
    PELINA, MD
    FARINA, AR
    NASON, AM
    HARTZLER, JL
    THORGEIRSSON, UP
    INVASION & METASTASIS, 1992, 12 (3-4): : 168 - 184
  • [38] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [39] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [40] Expression of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 in childhood acute lymphoblastic leukemia
    Mekawy, Mohamed A.
    Maksoud, Sahar S. Abdel
    Eissa, Doaa G.
    Abdelmaksoud, Abeer A.
    Ragab, Iman A.
    Sallam, Mahmoud T.
    Yousef, Adam A.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2012, 37 (04): : 274 - 280